Blog About: Treating Psoriasis When Enbrel Fails

Related Articles

For the approximately 7.5 million Americans affected by psoriasis, the thick, red, scaly, itchy plaques it causes only scratch the surface when it comes to the overall implications of this disease. Now, ongoing research linking psoriasis to other serious medical conditions and the incredible toll it can take on a person's overall quality of life are shifting the way psoriasis is viewed -- from a common skin disease to a complex systemic condition.

Clinical trials to test the effectiveness of two prescription drugs for the debilitating skin condition psoriasis have revealed significant differences that should help inform physicians treating patients with the condition.

Mo must know…It is very confusing with so many first cousins around of AHAs, Salicylic Acid, Glycolic Acid, Lactic Acid & Ammonium Lactate. Which one is the better one of these? I believe all of them essentially do the same job – They help with itching in KP/Eczema/Psoriasis, slough off dead skin, exfoliate, unplug pores, [...]

New research promises to pry some long held secrets from one of humanity's oldest known diseases. Scientists have discovered how to parse the most troublesome cells behind the debilitating skin lesions in psoriasis and have identified several distinctive markers that suggest how they might be contributing to the disease -- a painful inflammation of the skin that afflicts up to 2 percent of the U.S. population.

Scientists have drilled down on the molecular nitty-gritty that distinguishes the two most common forms of inflammatory skin disease, atopic eczema and psoriasis. The researchers say that the ability to distinguish between the disorders' genetic and immunological signatures opens the door for more narrowly targeted therapies sorely needed by the millions of people afflicted worldwide.

Share:

Latest Articles